154
Views
1
CrossRef citations to date
0
Altmetric
Review

Parental COPD as a Risk Factor for the Development of COPD and Disease Severity in Offspring: A Systematic Scoping Review

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 1323-1338 | Published online: 08 Jun 2022

References

  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/s0140-6736(17)31222-9
  • Roth G, Abate D, Abate K. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/s0140-6736(18)32203-7
  • Celli BR, Wedzicha JA, Drazen JM. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1257–1266. doi:10.1056/NEJMra1900500
  • Agusti A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1248–1256. doi:10.1056/NEJMra1900475
  • Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935–939. doi:10.1136/thx.2006.062802
  • Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD?–Report from the obstructive lung disease in Northern Sweden Studies. Respir Med. 2003;97(2):115–122. doi:10.1053/rmed.2003.1446
  • Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3–10. doi:10.1164/rccm.200901-0047OC
  • Lange P, Celli B, Agustí A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373(2):111–122. doi:10.1056/NEJMoa1411532
  • Agustí A, Noell G, Brugada J, Faner R. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med. 2017;5(12):935–945. doi:10.1016/s2213-2600(17)30434-4
  • Duan P, Wang Y, Lin R, et al. Impact of early life exposures on COPD in adulthood: a systematic review and meta-analysis. Respirology. 2021;26(12):1131–1151. doi:10.1111/resp.14144
  • Hooper R, Burney P, Vollmer WM, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J. 2012;39(6):1343–1353. doi:10.1183/09031936.00002711
  • Nihlen U, Nyberg P, Montnemery P, Lofdahl CG. Influence of family history and smoking habits on the incidence of self-reported physician’s diagnosis of COPD. Respir Med. 2004;98(3):263–270. doi:10.1016/j.rmed.2003.10.006
  • Montnemery P, Lanke J, Lindholm LH, et al. Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey. Eur J Epidemiol. 2000;16(11):1003–1007. doi:10.1023/a:1011004420173
  • Li LS, Paquet C, Johnston K, Williams MT. “What are my chances of developing COPD if one of my parents has the disease?” A systematic review and meta-analysis of prevalence of co-occurrence of COPD diagnosis in parents and offspring. Int J Chron Obstruct Pulmon Dis. 2017;12:403–415. doi:10.2147/copd.S123933
  • Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899–909. doi:10.1016/s0140-6736(14)60446-3
  • Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. doi:10.1186/s12874-018-0611-x
  • Peters MD, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: scoping Reviews (2020 version). Secondary Chapter 11: scoping Reviews (2020 version); 2020. Available from: https://synthesismanual.jbi.global. Accessed May 19, 2022.
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473. doi:10.7326/m18-0850
  • Veritas Health Innovation M, Australia. Covidence systematic review software. Available from www.covidence.org. Accessed May 19, 2022.
  • Moll M, Lutz SM, Ghosh AJ, et al. Relative contributions of family history and a polygenic risk score on COPD and related outcomes: cOPDGene and ECLIPSE studies. BMJ Open Respir Res. 2020;7(1):e000755. doi:10.1136/bmjresp-2020-000755
  • Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med. 1977;63(3):336–342. doi:10.1016/0002-9343(77)90270-4
  • Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med. 2011;184(4):414–420. doi:10.1164/rccm.201011-1928OC
  • Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1770–1778. doi:10.1164/ajrccm.157.6.9706014
  • Khoury MJ, Beaty TH, Tockman MS, Self SG, Cohen BH. Familial aggregation in chronic obstructive pulmonary disease: use of the log linear model to analyze intermediate environmental and genetic risk factors. Genet Epidemiol. 1985;2(2):155–166. doi:10.1002/gepi.1370020206
  • Higgins M, Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis. 1975;28(4):239–251. doi:10.1016/0021-9681(75)90053-3
  • Hersh CP, Hokanson JE, Lynch DA, et al. Family history is a risk factor for COPD. Chest. 2011;140(2):343–350. doi:10.1378/chest.10-2761
  • Zoller B, Li X, Sundquist J, Sundquist K. Familial transmission of chronic obstructive pulmonary disease in adoptees: a Swedish nationwide family study. BMJ open. 2015;5(4):e007310. doi:10.1136/bmjopen-2014-007310
  • Cosío BG, Pascual-Guardia S, Borras-Santos A, et al. Phenotypic characterisation of early COPD: a prospective case-control study. ERJ Open Res. 2020;6(4):00047–2020. doi:10.1183/23120541.00047-2020
  • McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med. 2001;164(8 Pt 1):1419–1424. doi:10.1164/ajrccm.164.8.2105002
  • Lu B, He Q. Correlation of pulmonary functions of COPD patients to those of their first-degree children. Chin Med J. 2003;116(7):991–995.
  • Amra B, Borougeni VB, Golshan M, Soltaninejad F. Pulmonary function tests and impulse oscillometry in severe chronic obstructive pulmonary disease patients’ offspring. J Res Med Sci. 2015;20(7):697–700. doi:10.4103/1735-1995.166229
  • Mostovoĭ IuM. Kliniko-geneticheskie issledovaniia pri khronicheskom bronkhite [Clinico-genetic research in chronic bronchitis]. Ter Arkh. 1988;60(3):52–55. Russian.
  • Goldman RE, Mennillo L, Stebbins P, Parker DR. How do patients conceptualize chronic obstructive pulmonary disease? Chron Respir Dis. 2017;14(3):245–255. doi:10.1177/1479972316680845
  • Martinez CH, Mannino DM, Jaimes FA, et al. Undiagnosed obstructive lung disease in the United States. Associated factors and long-term mortality. Ann Am Thorac Soc. 2015;12(12):1788–1795. doi:10.1513/AnnalsATS.201506-388OC
  • Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor’s diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005;72(5):471–479. doi:10.1159/000087670
  • Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-2535
  • Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. Lancet Respir Med. 2017;5(5):426–434. doi:10.1016/s2213-2600(17)30119-4
  • Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: family history in risk assessment for common diseases. Ann Intern Med. 2009;151(12):878–885. doi:10.7326/0003-4819-151-12-200912150-00177
  • Berg AO, Baird MA, Botkin JR, et al. National institutes of health state-of-the-science conference statement: family history and improving health. Ann Intern Med. 2009;151(12):872–877. doi:10.7326/0003-4819-151-12-200912150-00165
  • Li LS, Williams MT, Johnston KN, Frith P, Hyppönen E, Paquet C. Parental and life-course influences on symptomatic airflow obstruction. ERJ Open Res. 2020;6(1). doi:10.1183/23120541.00343-2019
  • Meigs JB, Cupples LA, Wilson PW. Parental transmission of type 2 diabetes: the Framingham offspring study. Diabetes. 2000;49(12):2201–2207. doi:10.2337/diabetes.49.12.2201
  • Williams RR, Hunt SC, Heiss G, et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol. 2001;87(2):129–135. doi:10.1016/s0002-9149(00)01303-5
  • Lloyd-Jones DM, Nam BH, D’Agostino RB Sr., et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291(18):2204–2211. doi:10.1001/jama.291.18.2204
  • Ørts LM, Bech BH, Lauritzen T, Carlsen AH, Sandbæk A, Løkke A. Lung function in adults and future burden of obstructive lung diseases in a long-term follow-up. NPJ Prim Care Respir Med. 2020;30(1):10. doi:10.1038/s41533-020-0169-z
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.